CN101112479A - Chinese traditional medicine for treating bone disease - Google Patents

Chinese traditional medicine for treating bone disease Download PDF

Info

Publication number
CN101112479A
CN101112479A CNA2007100124004A CN200710012400A CN101112479A CN 101112479 A CN101112479 A CN 101112479A CN A2007100124004 A CNA2007100124004 A CN A2007100124004A CN 200710012400 A CN200710012400 A CN 200710012400A CN 101112479 A CN101112479 A CN 101112479A
Authority
CN
China
Prior art keywords
rhizoma
radix
treatment
chinese medicine
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2007100124004A
Other languages
Chinese (zh)
Other versions
CN100546616C (en
Inventor
曲唯茵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QU YUEMIN
Original Assignee
QU YUEMIN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QU YUEMIN filed Critical QU YUEMIN
Priority to CNB2007100124004A priority Critical patent/CN100546616C/en
Publication of CN101112479A publication Critical patent/CN101112479A/en
Application granted granted Critical
Publication of CN100546616C publication Critical patent/CN100546616C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention relates to a traditional Chinese medicine for treating bone diseases. The present invention includes the following components according to the mix ratio by the weight parts : Chinese angelica: safflower: myrrh: frankincense: yanhusuo: Sanguis Draconis: sanchi: drynaria rhizome of fortune: pangolin scales: twotooth achyranthes root: Szechuan lovage rhizome: musk: east Asian tree fern rhizome is equivalent to 0.2 to 0.8: 0.2 to 0.8: 0.3 to 0.9: 0.3 to 0.9: 0.2 to 0.8: 0.1 to 0.3: 0.1 to 0.3: 0.9 to 1.5: 0.05 to 0.15: 0.1 to 0.5: 0.1 to 0.5: 0.02 to 0.07: 0.2 to 0.8. The medicine of the present invention inherits and develops the medical heritage of the motherland and follows the principle of treatment aiming at its pathogenesis and treating both manifestation and root cause of diseases, thus enabling the intervertebral disc to recover the naturally position after the intraspinal accumulating liquid being absorbed by the oral administration of the medicine, furthermore, the present invention has good effect of eliminating the accumulating liquid in the lumbar vertebral canal and has the advantages of short treatment course, fast efficiency, no recurrence after the cure and no toxicity or side effects for the treatment of lumbar disc herniation, hyperosteogeny, cervical spondylosis and other bone diseases.

Description

A kind of Chinese medicine for the treatment of osteopathia
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of osteopathia, especially relate to a kind of Chinese medicine for the treatment of prolapse of lumbar intervertebral disc, hyperosteogeny, cervical spondylosis.
Background technology
At present, osteopathia sickness rate in numerous crowds such as prolapse of lumbar intervertebral disc, hyperosteogeny, cervical spondylosis are higher, belong to commonly encountered diseases, frequently-occurring disease, and belong to worldwide difficult disease.But its performance simplified summary is 5 big symptoms: pain, swelling, hypertrophy, distortion, moving obstacle.The western medical treatment aspect has only physical methods such as physical therapy, massage, traction, sealing, small needle knife, finally adopts the method for operative treatment.But western medical treatment risk height, complication is arranged, not only surgery cost is high, and curative effect also is difficult to guarantee.It is old how sick that the patient mostly is again, increased the danger of operation, and general patient is unwilling to accept.And based on the expectant treatment of hormone, indometacin alleviating pain for the moment, drug withdrawal is promptly sent out.Some present Chinese medicines then exist the length course of treatment, slow shortcoming takes effect.
Summary of the invention
The technical problem to be solved in the present invention provides the Chinese medicine of a kind of short treating period, instant effect, treatment prolapse of lumbar intervertebral disc that cure rate is high, hyperosteogeny, cervical spondylosis.
In order to solve the problem that prior art exists, the technical solution used in the present invention is:
A kind of Chinese medicine for the treatment of osteopathia comprises following component and forms according to the following number of weight ratio:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii=0.2-0.8: 0.2-0.8: 0.3-0.9: 0.3-0.9: 0.2-0.8: 0.1-0.3: 0.1-0.3: 0.9-1.5: 0.05-0.15: 0.1-0.5: 0.1-0.5: 0.02-0.07: 0.2-0.8.
Described a kind of Chinese medicine for the treatment of osteopathia comprises following component and forms according to the following number of weight ratio:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii=0.3-0.7: 0.3-0.7: 0.4-0.8: 0.4-0.8: 0.3-0.7: 0.15-0.25: 0.15-0.25.1-1.4: 0.07-0.13: 0.2-0.4: 0.2-0.4: 0.03-0.06: 0.3-0.7.
Described a kind of Chinese medicine for the treatment of osteopathia comprises following component and forms according to the following number of weight ratio:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii=0.5: 0.5: 0.6: 0.6: 0.5: 0.2: 0.2: 1.2: 0.1: 0.3: 0.3: 0.05: 0.5.
Described a kind of Chinese medicine for the treatment of osteopathia, also form according to the following number of weight ratio by following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii: Radix Et Rhizoma Rhei=0.2-0.8: 0.2-0.8: 0.3-0.9: 0.3-0.9: 0.2-0.8: 0.1-0.3: 0.1-0.3: 0.9-1.5: 0.05-0.15: 0.1-0.5: 0.1-0.5: 0.02-0.07: 0.2-0.8: 0.05-0.15.
Described a kind of Chinese medicine for the treatment of osteopathia, also form according to the following number of weight ratio by following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii: Radix Et Rhizoma Rhei=0.3-0.7: 0.3-0.7: 0.4-0.8: 0.4-0.8: 0.3-0.7: 0.15-0.25: 0.15-0.25: 1-1.4: 0.07-0.13: 0.2-0.4: 0.2-0.4: 0.03-0.06: 0.3-0.7: 0.07-0.13.
Described a kind of Chinese medicine for the treatment of osteopathia, also form according to the following number of weight ratio by following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii: Radix Et Rhizoma Rhei=0.5: 0.5: 0.6: 0.6: 0.5: 0.2: 0.2: 1.2: 0.1: 0.3.0.3: 0.05: 0.5: 0.1.
Advantage and effect that the present invention had are:
Radix Angelicae Sinensis sweet in the mouth, suffering, warm in nature.Return liver, the heart, spleen channel.Having enriches blood invigorates blood circulation, the effect of dispersing cold for relieving pain, is used for the pain card of traumatic injury, wind-damp numbness.Rhizoma Chuanxiong nature and flavor suffering, temperature.Return liver, gallbladder, pericardium channel.Has blood circulation promoting and blood stasis dispelling, the effect of wind-expelling pain-stopping.Flos Carthami nature and flavor suffering, temperature.Return liver, heart channel.Effect with blood circulation promoting and blood stasis dispelling.Olibanum nature and flavor suffering, hardship, temperature.GUIXIN, liver, spleen channel.Has promoting blood circulation and stopping pain, detumescence and promoting granulation.Myrrha nature and flavor hardship, flat.GUIXIN, liver, spleen channel.Effect with promoting blood circulation and stopping pain, detumescence and promoting granulation.The Squama Manis nature and flavor are salty, are slightly cold.Return liver, stomach warp.Have that blood stasis dispelling stimulates the menstrual flow, the effect of detumescence and apocenosis.Radix Achyranthis Bidentatae nature and flavor hardship, acid, flat.Return liver, kidney channel.Having blood stasis dispelling stimulates the menstrual flow and cures the wound the effect of invigorating the liver and kidney, bone and muscle strengthening.The arduous temperature of Rhizoma Corydalis nature and flavor, GUIXIN liver spleen channel has blood-activating and qi-promoting analgesic effect, is used for trusted subordinate and limbs pain due to the coagulation of QI-blood.The Sanguis Draxonis nature and flavor are sweet, salty, and are flat.Go into heart born of the same parents, Liver Channel.Has clots absorbing, hemostasis, pain relieving, the effect of expelling pus and promoting granulation.The sweet cold of Radix Notoginseng nature and flavor has the effect of heat clearing away, suppressing the hyperactive liver, blood pressure lowering.Rhizoma Drynariae nature and flavor hardship, temperature.Go into kidney, heart channel.Be used for fracture and injury, diseases such as bones and muscles pain.Rhizoma Drynariae not only the kidney invigorating can be invigorated blood circulation again and hinder to treat folding with hard bone.The Moschus property and flavor of peppery and warm has the effect of promoting blood circulation to restore menstrual flow, reducing swelling and alleviating pain, and diseases such as traumatic pain, arthralgia pain numbness are had better curative effect.Rhizoma Cibotii nature and flavor hardship, sweet, temperature.The energy invigorating the liver and kidney, strong waist knee joint removes rheumatism.Control anemofrigid-damp arthralgia, the lumbago foot is soft.Radix Et Rhizoma Rhei nature and flavor bitter cold, the hardship reality of dispelling, cold can heat clearing away, have the effect of clots absorbing hemostatic.Motherland's medical heritage is inherited and developed to medicine of the present invention, in line with treatment must aim at the pathogenesis of disease, the principle for the treatment of both the principal and secondary aspects of a disease, by the oral drugs blood circulation promoting and blood stasis dispelling rachiochysis is absorbed, the symptom that canalis spinalis pressure reduces pressuring nerve alleviates naturally, easypro the meridian dredging allows hard pressed nerve obtain recovery from illness, by rachiochysis is absorbed, intervertebral disc is resetted naturally.The advantage that after having short treating period, instant effect aspect the osteopathia such as treatment prolapse of lumbar intervertebral disc, hyperosteogeny, cervical spondylosis, healing, does not recur, has no side effect.
The clinical efficacy report of medicine of the present invention
Provide clinical case by traditional Chinese medical science orthopaedics clinic, Road Inside Area, Harbin City, Heilongjiang Province city.
1, data and method
1.1 " traditional Chinese medical science disease diagnosis criterion of therapeutical effect " (publishing house of Nanjing University) of physical data basis " clinical osteology " (People's Medical Officer Press) diagnostic criteria and State Administration of Traditional Chinese Medicine in 1994 will meet the osteopathia patient of diagnostic criteria and be divided into treatment group and matched group at random.126 examples are organized in treatment, cervical spondylosis 24 examples (comprising hypertrophy 21 examples, cervical intervertebral disk bulging 3 examples) wherein, lumbar spondylosis 54 examples (comprising hypertrophy 9 examples, spinal canal stenosis 12 examples, intervertebral disk hernia 33 examples), gonarthrosis 48 examples (comprising hypertrophy 30 examples, hyperplastica synovitis 9 examples, rheumatic arthritis 9 examples).Matched group 120 examples, cervical spondylosis 23 examples (comprising hypertrophy 20 examples, cervical intervertebral disk bulging 3 examples) wherein, lumbar spondylosis 51 examples (comprising hypertrophy 9 examples, spinal canal stenosis 11 examples, annuler bulge 31 examples), gonarthrosis 46 examples (comprising hypertrophy 28 examples, hyperplastica synovitis 9 examples, rheumatic arthritis 9 examples).Two groups of case differences do not have significance (P>0.05), have comparability.
1.2 Therapeutic Method treatment group is selected the medicine of being made by the present invention for use, adult's four times a day is once taken 5 grams, uses warm water delivery service.No longer take the other medicines for the treatment of this type of disease during taking this medicine.Matched group is taken medicine " Kang Gule ", and adult's four times a day is once taken 5 grams, uses warm water delivery service, takes continuously four months.
2, result
2.1 criterion of therapeutical effect is according to " traditional Chinese medical science disease diagnosis criterion of therapeutical effect " (publishing house of Nanjing University) of " clinical osteology " (People's Medical Officer Press) curative effect judging standard and State Administration of Traditional Chinese Medicine in 1994, recovery from illness: clinical symptom disappearance, limb activity freely, imaging examination shows that outstanding position fully also receives; Produce effects: clinical symptoms obviously alleviates, and imaging examination shows that vertebra nuclear most also receives; Invalid: clinical symptoms is not improved, and imaging examination does not show improvement.
2.2 therapeutic effect
The routine number of fully recovering Produce effects example number Invalid routine number Total effective rate
Treatment group (126 example) 51 69 6 95.24%
Matched group (120 example) 20 57 43 64.17%
Two groups aspect total effective rate difference significance (P<0.01) is arranged.
3, conclusion
Medicine of the present invention is the vegetalitas medicine, and Rhizoma Chuanxiong, Flos Carthami etc. have blood circulation promoting and blood stasis dispelling, the effect of wind-expelling pain-stopping in the side; Olibanum, Myrrha, Rhizoma Corydalis, Moschus, Radix Angelicae Sinensis etc. have the effect of promoting blood circulation and stopping pain, detumescence and promoting granulation; Radix Et Rhizoma Rhei has the effect of row's stasis of blood.All medicines cooperate energy alleviating pain, reducing swelling and alleviating pain, promote the absorption of rachiochysis, promote local blood circulation, improve the limb function activity, reduce recurrence, and through observing clinical 126 routine osteopathia patients, curative effect all is better than matched group.Safety of medicine of the present invention has no side effect.Observation to contents such as the heart, liver, kidney and hemogram before and after the treatment shows that drug safety of the present invention is good, the harmless and toxic and side effects to the heart, liver, kidney and hemopoietic function.
4, model case
Patient Wang Guilian, sex man, 72 years old.Main suit's dizziness, shoulder back of the body constriction, numbness of hand wood, two weakness of the lower extremities feel like jelly.First visit CT display fibers ring breakage C5-6 hyperosteogeny, the cervical spinal canal gap is narrow and small, and it is straight that the physiology curvature becomes, and the diagnosis cervical spinal canal is narrow.Take medicine four times a day of the present invention, one time 5 gram is taken a month shoulder back of the body constriction and is alleviated, and takes two months weakness of the lower extremities symptoms and obviously alleviates, and recovers normal in four months, follows up a case by regular visits to not recurrence in a year.
Patient Wang Lixia, age 46, sex woman.Main suit's waist persistence is paused bitterly, the radiation of compressing sciatic nerve causes that buttocks and thigh go up painful, and lumbosacral region diffusivity pain is failed to respond to any medical treatment through massage traction, CT waist L4-5 lip sample hypertrophy is seen in first visit, the dural sac nerve compression, lateral recess stenosis lumbar vertebra L4 slippage once, diagnosis prolapse of lumbar intervertebral disc, take medicine of the present invention every day 4 times, one time 5 gram is taken to go up painful after one month and is alleviated, and waist and sacrum pain and shank go up painful to disappear and recover normally to follow up a case by regular visits to not recurrence in a year after three months
Patient Li Jie, sex woman, 67 years old.Main suit's 11 years nearest state of an illness of falling ill increase the weight of, the lumbago numbness of lower limbs, and waist tunks pain with left buttocks and Calf muscle atrophy, and weakness of the lower extremities is not felt any better through multi-treatment.First visit sees that CT shows that the L3-4 opisthodetic ligament is ossified, and hypertrophy of ligamentum flavum is with intervertebral foramina stenosis, L5 sclerotin vacuum disease, waist L4 compression fracture, diagnosis lumbar spinal stenosis.Take medicine one time 5 gram every day 4 times of the present invention, painful after two months fiber crops alleviate, and the weakness of the lower extremities sense alleviates.Take continuously after 5 months and recover normal physiological function, follow up a case by regular visits to not recurrence in a year.
Patient Liu Wei, man, 27 years old.Waist buttocks acid distending pain 4 years, neck aching pain in should and back 3 years.The waist trauma history is arranged when young, and the lumbago that happened suddenly before 4 years, and the state of an illness is by increasing the weight of can not the walking for a long time sitting, can not bend over.Again because of causing neck pain in the shoulder and back companion malaise after having a cold, can not lean over a book later on.Check when seeing a doctor: the other flesh convulsion of pelvic bone two side waist spinous process tenderness, two side iliotibial tract all have tenderness, and two side quadriceps reflexs are drawn, straight-leg raising test (-).It is slightly outstanding to look into waist CT:L4.5 intervertebral disc, and corresponding dural sac is pressurized slightly.Two side neck spinous process are other all tenderness, upper and lower flesh in two side hilllocks and large and small rhomboideus, and large and small garden flesh all has tenderness, Hoffmann ' s (-).Diagnosis: the 1. prominent disease of waist.2. the neck shoulder is carried on the back soft tissue injury.Treatment: the oral medicine of being made by the present invention, four times a day is once taken 5 grams, takes continuously that the state of an illness takes a turn for the better to some extent after three months, continues to take medicine of the present invention and reaches after 2 months and be almost recovered, and follows up a case by regular visits to not recurrence in 1 year.
Patient Zhai Zhenlei, man 31 years old, lumbar intervertebral disc L4-5 bulging, the waist persistence is paused bitterly, and the radiation of compressing sciatic nerve causes that buttocks and thigh go up painful, and the neural slight pressurized of dural sac is not seen lumbar spinal stenosis, diagnoses lumbar intervertebral disc prolapse.Treatment: the oral medicine of being made by the present invention, four times a day is once taken 5 grams, takes after one month patient's buttocks and legs continuously and goes up painful and alleviate transference cure after continuing to take medicine three months.
The specific embodiment
Embodiment 1:
A kind of Chinese medicine for the treatment of osteopathia, also form according to the following number of weight ratio by following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii=0.2: 0.8: 0.9: 0.9: 0.8: 0.3: 0.3: 1.5: 0.15: 0.5: 0.5: 0.07: 0.8.
The preparation method of medicine of the present invention:
Get the 80 purpose powder that become by above-mentioned raw materials medicated powder according to the above ratio respectively, fully get final product behind the mix homogeneously.
Embodiment 2:
A kind of Chinese medicine for the treatment of osteopathia, also form according to the following number of weight ratio by following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii=0.8: 0.2: 0.3: 0.3: 0.2: 0.1: 0.1: 0.9: 0.05: 0.1: 0.1: 0.02: 0.2.
Its preparation method is with embodiment 1.
Embodiment 3:
A kind of Chinese medicine for the treatment of osteopathia, also form according to the following number of weight ratio by following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii=0.3: 0.7: 0.8: 0.8: 0.7: 0.25: 0.25: 1.4: 0.13: 0.4: 0.4: 0.06: 0.7.
Its preparation method is with embodiment 1.
Embodiment 4:
A kind of Chinese medicine for the treatment of osteopathia, also form according to the following number of weight ratio by following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii=0.7: 0.3: 0.4: 0.4: 0.3: 0.15: 0.15: 1: 0.07: 0.2: 0.2: 0.03: 0.3.
Its preparation method is with embodiment 1.
Embodiment 5:
A kind of Chinese medicine for the treatment of osteopathia, also form according to the following number of weight ratio by following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii=0.5: 0.5: 0.6: 0.6: 0.5: 0.2: 0.2: 1.2: 0.1: 0.3: 0.3: 0.05: 0.5.
Its preparation method is with embodiment 1.
Embodiment 6:
A kind of Chinese medicine for the treatment of osteopathia, also form according to the following number of weight ratio by following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii=0.4: 0.4: 0.5: 0.5: 0.6: 0.23: 0.23: 1.3: 0.09: 0.35: 0.35: 0.04: 0.6.
Its preparation method is with embodiment 1.
Embodiment 7:
A kind of Chinese medicine for the treatment of osteopathia, also form according to the following number of weight ratio by following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii: Radix Et Rhizoma Rhei=0.6: 0.6: 0.5: 0.5: 0.4: 0.18: 0.18: 1.3: 0.11: 0.35: 0.35: 0.04: 0.4: 0.09.
Its preparation method is with embodiment 1.
Embodiment 8:
A kind of Chinese medicine for the treatment of osteopathia, also form according to the following number of weight ratio by following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii: Radix Et Rhizoma Rhei=0.2: 0.8: 0.9: 0.9: 0.8: 0.3: 0.3: 1.5: 0.15: 0.5: 0.5: 0.07: 0.8: 0.15.
Its preparation method is with embodiment 1.
Embodiment 9:
A kind of Chinese medicine for the treatment of osteopathia, also form according to the following number of weight ratio by following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii: Radix Et Rhizoma Rhei=0.8: 0.2: 0.3: 0.3: 0.2: 0.1: 0.1: 0.9: 0.05: 0.1: 0.1: 0.02: 0.2: 0.05.
Its preparation method is with embodiment 1.
Embodiment 10:
A kind of Chinese medicine for the treatment of osteopathia, also form according to the following number of weight ratio by following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii: Radix Et Rhizoma Rhei=0.3: 0.7: 0.8: 0.8: 0.7: 0.25: 0.25: 1.4: 0.13: 0.4: 0.4: 0.06: 0.7: 0.13.
Its preparation method is with embodiment 1.
Embodiment 11:
A kind of Chinese medicine for the treatment of osteopathia, also form according to the following number of weight ratio by following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii: Radix Et Rhizoma Rhei=0.7: 0.3: 0.4: 0.4: 0.3: 0.15: 0.15: 1: 0.07: 0.2: 0.2: 0.03: 0.3: 0.07.
Its preparation method is with embodiment 1.
Embodiment 12:
A kind of Chinese medicine for the treatment of osteopathia, also form according to the following number of weight ratio by following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii: Radix Et Rhizoma Rhei=0.5: 0.5: 0.6: 0.6: 0.5: 0.2: 0.2: 1.2: 0.1: 0.3: 0.3: 0.05: 0.5: 0.1.
Its preparation method is with embodiment 1.

Claims (6)

1. Chinese medicine for the treatment of osteopathia is characterized in that comprising following component and forms according to the following number of weight ratio:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii=0.2-0.8: 0.2-0.8: 0.3-0.9: 0.3-0.9: 0.2-0.8: 0.1-0.3: 0.1-0.3: 0.9-1.5: 0.05-0.15: 0.1-0.5: 0.1-0.5: 0.02-0.07: 0.2-0.8.
2. a kind of Chinese medicine for the treatment of osteopathia according to claim 1 is characterized in that comprising following component and forms according to the following number of weight ratio:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii=0.3-0.7: 0.3-0.7: 0.4-0.8: 0.4-0.8: 0.3-0.7: 0.15-0.25: 0.15-0.25: 1-1.4: 0.07-0.13: 0.2-0.4: 0.2-0.4: 0.03-0.06: 0.3-0.7.
3. a kind of Chinese medicine for the treatment of osteopathia according to claim 1 is characterized in that comprising following component and forms according to the following number of weight ratio:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii=0.5: 0.5: 0.6: 0.6: 0.5: 0.2: 0.2: 1.2: 0.1: 0.3: 0.3: 0.05: 0.5.
4. a kind of Chinese medicine for the treatment of osteopathia according to claim 1 is characterized in that also being made up of according to the following number of weight ratio following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii: Radix Et Rhizoma Rhei=0.2-0.8: 0.2-0.8: 0.3-0.9: 0.3-0.9: 0.2-0.8: 0.1-0.3: 0.1-0.3: 0.9-1.5: 0.05-0.15: 0.1-0.5: 0.1-0.5: 0.02-0.07: 0.2-0.8: 0.05-0.15.
5. a kind of Chinese medicine for the treatment of osteopathia according to claim 1 is characterized in that also being made up of according to the following number of weight ratio following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii: Radix Et Rhizoma Rhei=0.3-0.7: 0.3-0.7: 0.4-0.8: 0.4-0.8: 0.3-0.7: 0.15-0.25: 0.15-0.25: 1-1.4: 0.07-0.13: 0.2-0.4: 0.2-0.4: 0.03-0.06: 0.3-0.7: 0.07-0.13.
6. a kind of Chinese medicine for the treatment of osteopathia according to claim 1 is characterized in that also being made up of according to the following number of weight ratio following component:
Radix Angelicae Sinensis: Flos Carthami: Myrrha: Olibanum: Rhizoma Corydalis: Sanguis Draxonis: Radix Notoginseng: Rhizoma Drynariae: Squama Manis: Radix Achyranthis Bidentatae: Rhizoma Chuanxiong: Moschus: Rhizoma Cibotii: Radix Et Rhizoma Rhei=0.5: 0.5: 0.6: 0.6: 0.5: 0.2: 0.2: 1.2: 0.1: 0.3: 0.3: 0.05: 0.5: 0.1.
CNB2007100124004A 2007-08-07 2007-08-07 A kind of Chinese medicine for the treatment of osteopathia Expired - Fee Related CN100546616C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2007100124004A CN100546616C (en) 2007-08-07 2007-08-07 A kind of Chinese medicine for the treatment of osteopathia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2007100124004A CN100546616C (en) 2007-08-07 2007-08-07 A kind of Chinese medicine for the treatment of osteopathia

Publications (2)

Publication Number Publication Date
CN101112479A true CN101112479A (en) 2008-01-30
CN100546616C CN100546616C (en) 2009-10-07

Family

ID=39021108

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2007100124004A Expired - Fee Related CN100546616C (en) 2007-08-07 2007-08-07 A kind of Chinese medicine for the treatment of osteopathia

Country Status (1)

Country Link
CN (1) CN100546616C (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101390967B (en) * 2008-11-05 2010-12-08 杨顺庆 Medicine composition for treating osteoporosis
CN101972377A (en) * 2010-09-29 2011-02-16 韩世昌 Traditional Chinese medicinal composition for treating aseptic necrosis of femoral head and preparation method thereof
CN104606414A (en) * 2015-03-09 2015-05-13 济南方宇文化传媒有限公司 Composition for treating hyperostosis and preparation method for composition
CN105395608A (en) * 2015-12-30 2016-03-16 周金峰 Traditional Chinese medicine composition for treating bone fractures and preparing method thereof
CN105833178A (en) * 2016-04-26 2016-08-10 于龙 Traditional Chinese medicine composition for treating bone injuries and bone diseases
CN107184774A (en) * 2017-05-24 2017-09-22 杨州 It is a kind of to control the traditional Chinese medical science pill for curing the wound and becoming silted up and becoming sick
CN111939192A (en) * 2020-08-28 2020-11-17 凉山新鑫中药饮片有限公司 A Chinese medicinal composition for treating prolapse of lumbar intervertebral disc and hyperosteogeny, and its preparation method
CN113230297A (en) * 2021-03-29 2021-08-10 邱晓辉 Powder for treating hydrops of muscles and bones and preparation method thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102319316B (en) * 2011-09-20 2014-04-02 韩必芝 Rapid bone hyperplasia healing agent

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101390967B (en) * 2008-11-05 2010-12-08 杨顺庆 Medicine composition for treating osteoporosis
CN101972377A (en) * 2010-09-29 2011-02-16 韩世昌 Traditional Chinese medicinal composition for treating aseptic necrosis of femoral head and preparation method thereof
CN104606414A (en) * 2015-03-09 2015-05-13 济南方宇文化传媒有限公司 Composition for treating hyperostosis and preparation method for composition
CN105395608A (en) * 2015-12-30 2016-03-16 周金峰 Traditional Chinese medicine composition for treating bone fractures and preparing method thereof
CN105833178A (en) * 2016-04-26 2016-08-10 于龙 Traditional Chinese medicine composition for treating bone injuries and bone diseases
CN107184774A (en) * 2017-05-24 2017-09-22 杨州 It is a kind of to control the traditional Chinese medical science pill for curing the wound and becoming silted up and becoming sick
CN111939192A (en) * 2020-08-28 2020-11-17 凉山新鑫中药饮片有限公司 A Chinese medicinal composition for treating prolapse of lumbar intervertebral disc and hyperosteogeny, and its preparation method
CN113230297A (en) * 2021-03-29 2021-08-10 邱晓辉 Powder for treating hydrops of muscles and bones and preparation method thereof

Also Published As

Publication number Publication date
CN100546616C (en) 2009-10-07

Similar Documents

Publication Publication Date Title
CN100546616C (en) A kind of Chinese medicine for the treatment of osteopathia
CN100376276C (en) Soothe tendons and activating-blood anodyne plaster
CN1118285C (en) Shubi plaster for treating arthralgia due to wind-cold-dampness
CN101797327B (en) Chinese medicinal preparation for treating pain caused by orthopedic diseases
CN105982976B (en) Treat bone penetrating fluid of bone and joint diseases and preparation method thereof
CN102895460B (en) Traditional Chinese medicine composition for fracture and soft tissue injury
CN101757148A (en) Traditional Chinese medicine composition for treating cervical spondylosis
CN101664455B (en) Chinese medicinal composition for treating lumbago and preparation method
CN102772619B (en) Traditional Chinese medicine for treating bone impediment
CN104000993A (en) Pills with effects of strengthening bones and stretching muscles and tendons and preparation technology thereof
CN103720851A (en) Traditional Chinese medicinal decoction for treating osteoproliferation
CN103463261B (en) Traditional Chinese medicine preparation for treating lumbar intervertebral disc herniation
CN104825563B (en) A kind of Chinese medicine preparation treating cervical spondylosis and preparation method thereof
CN103830578B (en) Be used for the treatment of the plaster of prolapse of lumbar intervertebral disc disease
CN106039244A (en) Traditional Chinese medicine for treating heumatism and preparation method
CN1895633A (en) Chinese-medicinal suppository for treating cervical spondylosis and its preparation
CN104857218B (en) A kind of nursing medicine treating prolapse of lumbar intervertebral disc
CN104666681A (en) Cataplasm for treating lumbar interveterbral disc protrusion
CN101954043A (en) Medicament for treating hyperosteogeny and preparation method thereof
CN102784360B (en) Traditional Chinese medicine composition for treating lumbar disc herniation and lumbar spine bone hyperplasia
CN106511696A (en) Soup for invigorating kidney, reinforcing tendon and strengthening waist
CN103550434B (en) A kind of externally applied liniment for the treatment of rheumatism bone injury ache
CN102908605B (en) Orthopedic combination for external use and preparation method and use thereof
CN105343862A (en) Drug composition for soft tissue injury and fracture
CN105213815A (en) Chinese medicine composition being used for the treatment of cervical spondylosis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20091007

Termination date: 20190807